Brevan Howard Capital Management’s Innospec IOSP Stock Holding History

Brevan Howard Capital Management’s Portfolio IOSP Stock Details IOSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.43M	Sell	17,540 -6,896	-28%	-$546K	0.01%	888
2026 Q1	$1.78M	Buy	24,436 +10,974	+82%	+$854K	0.02%	605
2025 Q4	$1.03M	Sell	13,462 -4,722	-26%	-$357K	0.01%	754
2025 Q3	$1.4M	Buy	18,184 +9,131	+101%	+$762K	0.01%	745
2025 Q2	$761K	Sell	9,053 -1,656	-15%	-$145K	﹤0.01%	1192
2025 Q1	$1.01M	Buy	10,709 +3,207	+43%	+$339K	0.01%	491
2024 Q4	$826K	Buy	+7,502	New	+$859K	0.01%	478
2024 Q3	–	Sell	-3,022	Closed	-$373K	–	1285
2024 Q2	$373K	Buy	+3,022	New	+$378K	﹤0.01%	705

Other funds holding IOSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Brevan Howard Capital Management's IOSP Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Innospec (IOSP) stake by 28% in Q2 2026, selling an estimated $546K and leaving 17,540 shares worth $1.43M. The position accounts for 0.01% of the portfolio, ranked #888.

Brevan Howard Capital Management first reported a position in IOSP in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.78M in Q1 2026. 282 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.

Brevan Howard Capital Management held 17,540 shares of Innospec worth $1.43M as of Q2 2026.
Brevan Howard Capital Management sold 6,896 Innospec shares in Q2 2026, an estimated $546K.
Innospec made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #888 holding.
Brevan Howard Capital Management first reported a position in Innospec in Q2 2024 and has held it in 8 quarters since.
Brevan Howard Capital Management's Innospec position peaked at $1.78M in Q1 2026.
282 funds tracked by Wall St. Rank held Innospec as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.